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Abstract
Background: Recently the reduction of the retinal nerve fibre layer (RNFL) was suggested to be associated with diffuse
axonal damage in the whole CNS of multiple sclerosis (MS) patients. However, several points are still under discussion. (1) Is
high resolution optical coherence tomography (OCT) required to detect the partly very subtle RNFL changes seen in MS
patients? (2) Can a reduction of RNFL be detected in all MS patients, even in early disease courses and in all MS subtypes? (3)
Does an optic neuritis (ON) or focal lesions along the visual pathways, which are both very common in MS, limit the
predication of diffuse axonal degeneration in the whole CNS? The purpose of our study was to determine the baseline
characteristics of clinical definite relapsing-remitting (RRMS) and secondary progressive (SPMS) MS patients with high
resolution OCT technique.
Methodology: Forty-two RRMS and 17 SPMS patients with and without history of uni- or bilateral ON, and 59 age- and sex-
matched healthy controls were analysed prospectively with the high resolution spectral-domain OCT device (SD-OCT) using
the Spectralis 3.5mm circle scan protocol with locked reference images and eye tracking mode. Furthermore we performed
tests for visual and contrast acuity and sensitivity (ETDRS, Sloan and Pelli-Robson-charts), for color vision (Lanthony D-15),
the Humphrey visual field and visual evoked potential testing (VEP).
Principal Findings: All 4 groups (RRMS and SPMS with or without ON) showed significantly reduced RNFL globally, or at
least in one of the peripapillary sectors compared to age-/sex-matched healthy controls. In patients with previous ON
additional RNFL reduction was found. However, in many RRMS patients the RNFL was found within normal range. We found
no correlation between RNFL reduction and disease duration (range 9–540 months).
Conclusions: RNFL baseline characteristics of RRMS and SPMS are heterogeneous (range from normal to markedly reduced
levels).
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Introduction
A recently broadly discussed hypothesis is that analysis of the
retina nerve fibre layer (RNFL) may be useful to track
degenerative processes in the central nervous system (CNS) [1–
2]. In previous studies on patients with multiple sclerosis (MS)
axonal loss in the RNFL was found to be correlated to visual
impairment, and interestingly to disability scores composed of
other than visual CNS dysfunctions (e.g. motor system) [3]. These
findings suggested that in MS the damage affecting the entire CNS
may be visualized by scanning the damage in the RNFL and in the
optic discs. However, since standard time-domain optical
coherence tomography (TD-OCT) was developed to detect or
monitor rather gross pathologies such as glaucoma, retinal
tumours, macula oedema, it is currently unclear if RNFL changes
of some micrometers are even detectable, and if so reliably
measurable with TD-OCT [4,5]. Apart from that, several other
issues must be clarified. First, it is conceivable that prior clinically
silent or apparent episodes of optic neuritis or focal lesions along
the visual pathway, which are both very common in MS, may also
lead to RNFL reduction. If so, a predication of global and more
subtle progressive axonal degeneration would be very difficult.
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13877Secondly, the true extent of focal MS lesions can hardly be
specified, when they were clinically silent, ignored or at least not
remembered by the patients, or were undetectable by magnetic
resonance imaging (MRI) or spectroscopy [6–8]. Thirdly,
technical limitations must be kept in mind. As prolonged
examination time and poor fixation result in motion artefacts
and decentred image scans, the use of TD-OCT seems restricted
for follow-up examinations [9–11]. In contrast the newly
developed high-resolution spectral-domain OCT (SD-OCT)
imaging technology overcomes these technical limitations of TD-
OCT markedly. With SD-OCT ultra-high speed retina scanning
image artefacts due to dispositioning of the scan detector, eye
movements or poor fixation can be avoided [11]. Most
importantly, identical scanning locations can be adjusted over
time, and thus, follow-up examinations easily performed [10].
In our study we used a new high-resolution SD-OCT to analyse
the RNFL in a large cohort of well classified patients with clinically
definite relapsing-remitting (RRMS) or secondary progressive MS
(SPMS) and healthy age- and sex matched controls to RNFL
characteristics at baseline [12]. Additionally, visual and contrast
sensitivity scores, color vision, visual field testing, and visual
evoked potentials were performed. Most importantly, in our study
results of MS eyes with and without history of ON were
distinguished, and separately analysed.
Methods
Participants
The study was approved by the local Ethics Committee
(Commission of Medical Ethics of Vienna; Ethic Approval/
Registration Number: EK-08-028-0308 and Ethical commission of
the Medical University of Vienna; Ethic Approval/Registration
Number: 414/2008). Informed written consent was obtained from
all patients and volunteers before study entry.
We studied 59 patients with clinically definite MS, and 59 sex-
and age matched healthy controls [12]. MS diagnosis was based
on clinical course, MRI and on cerebrospinal fluid (CSF) analysis.
Oligoclonal bands were found in all MS CSF samples. Forty-two
MS patients followed a relapsing-remitting course (RRMS) and 17
MS patients a secondary progressive course (SPMS). In 5 cases
with recurrent optic neuritis and 3 with myelitis the analysed sera
were negative for aquaporin-4 autoantibodies [13]. Thirteen
RRMS and 11 SPMS had a history of prior ON. A summary of all
MS patients and controls is given in table 1.
Exclusion criteria
Patients with other diseases that reduce RNFL thickness such as
glaucoma, anterior ischemic optic neuropathy, high myopia, and
congenital abnormalities of the optic nerves were excluded.
Baseline clinical neurological examinations, visual evoked
potentials (VEP), and ophthalmologic examinations were per-
formed within 7 days. The patients’ history and available medical
records were carefully reviewed for previous ON. The diagnosis of
ON was based on clinical findings, which included the presence of
decreased visual acuity, a visual field defect, colour vision loss,
relative afferent pupil defect, and a compatible fundus examina-
tion. No included patient had an ON within 12 months prior to
the beginning of the study.
Visual function testing
Visual function testing (best corrected visual acuity and
sensitivity) was performed in MS patients and controls using
low-contrast Sloan letter charts (retro-illuminated version, Preci-
sion Vision, IL) at 10% and at 5% low-contrast levels and Pelli-
Robson contrast sensitivity chart and at full contrast (100%
ETDRS 2000 chart, testing high-contrast visual acuity). All testing
was performed monocularly and with both eyes together. If one
eye was visually worse, this eye was tested first followed by the
better eye; binocular testing was performed last. The results were
recorded as the number of letters correctly identified (with a
maximum of 60 letters per chart, each line =5 letters for the
ETDRS and Sloan chart and a maximum of 48 letters with 6
letters each line for the Pelli-Robson chart). Both patients and
controls were asked to use their glasses/contact lenses to correct
for the testing.
Visual Field Analysis
Visual field analysis was obtained with Humphrey perimetry
using the SITA algorithm (Zeiss Meditech, Dublin, CA). For the
purposes of comparing visual field function (measured in decibels
to the mean RNFL thickness (measured in micrometers), we used
central 30-2, full-threshold strategy testing [14].
RNFL Measurement
The high resolution SD-OCT uses a scanning superlumines-
cence diode to emit a scan beam with a wavelength of 870 nm to
provide up to 40.000 A scans/sec with a depth resolution of 7 mm
in tissue and a transversal resolution of 14 mm of images of ocular
microstructures (Heidelberg Engineering, Heidelberg, Germany,
Spectralis software version 4.0.3.0, Eye Explorer Software 1.6.1.0).
The instrument combines OCT technology with a confocal
Scanning Laser Ophthalmoscope (Heidelberg Engineering, Hei-
delberg, Germany), which provides a reference fundus image. By
means of eye tracking (TrueTrac
TM) each peripapillary OCT scan
will be registered and locked to a reference image. OCT software
can identify previous scan locations and ‘‘guide’’ the OCT laser
beam to scan the same location again. For this purpose, eye
tracking and the high scanning speed is supposed to reduce
artefacts resulting from eye movement. For OCT scanning, the
high-resolution SD-OCT provides an Automatic Real-Time
averaging mode (ART mode) which when activated enables the
operator to adjust the number of obtained frames (B scans) to
average images for increased image quality. In this study, this was
achieved by a total of 16 frames (maximum available number of
image frames) of the same scanning location during the
peripapillary scanning process thereby optimizing the signal to
noise ratio and image quality significantly. Examination time is not
the same as scanning speed. Although scanning speed of the high-
resolution SD-OCT for a B-scan image is extremely fast,
performing up to 40.000A scans/sec, B scans, however, will only
be performed if the eye tracking software recognizes the exact
scanning position in the fundus image. Scans were acquired in the
high-resolution acquisition mode allowing a more detailed
differentiation of retinal layers, with pupil dilation.
An internal fixation light was used to centre the scanning area
on the disc. To obtain excellent centring, the incorporated circle-
shaped target area was placed on the optic disc and performed
scans were obtained within a single session on all eyes. Scans were
performed with activated ART mode during measurements with
locked target area over the fixed optic disc reference image for
several scans. RNFL scans were performed several times by one
operator (N.S.) within one session until at least 3 high-quality scans
were achieved and used for further analysis.
Furthermore, signal strength has been shown to affect RNFL
thickness measurements using conventional Stratus OCT [15–16]
(Figure 1, manuscript in preparation). Therefore, scans with low
quality and failing RNFL segmentation were excluded. Measure-
ments were repeated until excellent quality was achieved. Criteria
High Resolution SD-OCT in MS
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before and during image acquisition, (2) absence of scan or
algorithm failures, (3) even and dense grey scale saturation
throughout all retinal layers with dense grey visible in the RPE,
and (4) the RNFL visible without missing or blank areas and a
continuous scan pattern.
Visual evoked potentials (VEP)
VEP were performed with essentially the same protocol as
described in very detail previously [17].
Statistics
Qualitative variables were summarized by minimum, maxi-
mum, mean and standard deviation, and by frequency tables. P-
values below 0.05 were considered statistically significant. We
performed the Bonferroni-Holm procedure for the comparisons in
Figure 2 and Figure 3 (separately for each figure) and present the
corresponding multiplicity adjusted p-values. Multiplicity adjusted
p-values are larger than the raw p-values and can directly be
compared to the 5% significance level. The model assumptions for
the random effect models are investigated by residual plots and q-
q-plots. All analyses were performed with the statistical software
package R version 2.9.0, in particular, the R-package nlme.
We compared the influence of disease status (RRMS versus
SPMS) and prior optic neuritis (ON) on RNFL by forming four
different MS-groups, namely, RRMS eyes with and without ON,
SPMS eyes with and without ON (groups 2 and 4, respectively)
and age/sex-matched healthy controls. We analyzed the overall
mean (global) and sector wise RNFL values by a random effect
model with two nested random factors accounting for a correlation
of measurements within matched pairs and patients. Similar
analyses of global measurements were done within the group of
patients with one ON-free and one ON fellow eye.
We furthermore investigated the influence of age at the time of
OCT measurement, MS group (RRMS and SPMS with/without
ON), and disease duration (change of RNFL per decade) in a
mixed model for patient eyes including the three fold interaction
term for sector, disease group and disease duration. The main
intention of this analysis was to investigate whether disease
duration influences the RNFL in MS patients with ‘ON free eyes’
or not. The overall effect of a prior ON episode on the mean
RNFL is estimated by a random effect models with ON (yes/no) as
single fixed factor and the patient as random factor.
The correlation of full-contrast visual acuity (EDTRS, Pelli-
Robson and Sloan charts), Lanthony desaturated colour vision
test, and the ‘‘Mean Deviation’’ of the Humphrey visual field
analysis with RNFL was investigated by mixed models where each
of the tests was taken as a single fixed effect and age at OCT as
additional random factor. The mean RNFL loss associated with a
one line decrease in EDTRS, SLOAN 5% and 10% (loss of 5
letters) and in the PR scale (loss of 6 letters) is estimated by the
mixed model of the sector-wise data when there is a no significant
interaction between sector and visual test and otherwise from a
mixed-effect model for the mean (=global, figure 3) RNFL. The
correlation between RNFL and ‘‘Mean deviation’’ (MD) in visual
field analysis or P-100 latencies was investigated by similar mixed
models. We furthermore investigated by a logistic regression
analysis with a robust variance estimate (generalized estimation
equation approach) the influence of the RNFL on the likelihood
for a P100 below 118 ms and for a MD variation $ 62.5 decibel.
To verify the company standard values, estimates and 95%
confidence intervals for the mean RNFL were determined from
the control group with variance component models for each
sector. The variance component models were performed to
account for the correlation between the two eyes of a control
person. Company standard values are compared to the 95%
intervals.
Results
Company standard values
The 95% confidence intervals of RNFL measurements for
controls and different disease groups and the standard values of
the OCT company are given in Table 2.
Table 1
MS cases with and without Optic Neuritis (ON) MS cases with Optic Neuritis (ON)
No
age (years)
[range]
disease duration
(months) [range] all Relapses No
age (years)
[range]
disease duration
(months) [range] all Relapses all ON
Controls 59 38.961.35
[21 to 67.0]
-- - - - - -
RRMS &
SPMS,
total
59 3961.4
[19.8 to 68.0]
121.1614.2 4.560.4
[1 to 19]
24 40.762.4
[19.8 to 68.0]
161.4621.1
[25.0 to 350.0]
4.560.4
[1 to 19]
1.860.2
[1 to 4]
RRMS,
total
42 37.661.7
[19.8 to 68.0]
90.3615.2
[9.0 to 540.0]
3.860.3
[1 to 10]
13 38.863.8
[19.8 to 68.0]
117.3621.9
[25.0 to 324.0]
4.660.6
[2 to 9]
2.060.3
[1 to 4]
RRMS,
female
31 37.162.2
[19.8 to 68.0]
101.2618.8
[14.0 to 540.0]
4.160.4
[2 to 9]
12 38.963.8
[19.8 to 68.0]
117.3621.9
[25.0 to 324.0]
4.660.6
[2 to 9]
2.160.3
[1 to 4]
RRMS,
male
11 38.362.3
[25.0 to 52.0]
56.6622.4
[9.0 to 240.0]
3.060.7
[1 to 10]
13 3 2 5 2 1
SPMS,
total
17 43.062.2
[26.0 to 56.0]
197.2623.8
[40.0 to 350.0],
3.361.0
[1 to 19]
11 42.962.8
[26.0 to 53.5]
213.5632.3
[40.0 to 350.0]
5.860.8
[3 to 12]
1.560.2
[1 to 2]
SPMS,
female
10 45.062.8
[27.0 to 56.0]
210.4634.2
[40.0 to 350.0],
3.060.7
[1 to 10]
6 46.662.7
[35.8 to 53.5]
236.8650.8
[40.0 to 350.0]
5.861.3
[3 to 12]
1.760.2
[1 to 2]
SPMS,
male
7 40.963.7
[26.0 to 52.0]
148.4632.7
[78.0 to 282.0]
6.561.6
[3 to 19]
5 38.564.9
[26.0 to 52.0]
102.638.9
[102.0 to 282.0]
5.861.2
[3 to 10]
1.460.2
[1 to 2]
doi:10.1371/journal.pone.0013877.t001
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confidence intervals of the control group only in sectors T and NI
but not in sectors TI, TS, N and NS were the company standard
value is at the border (sector TI) or quite below the lower
confidence limits (sectors TS, N, NS, see Table 2). Using company
standards as opposed to a real matched control group may
therefore result in an underestimation of RNFL alterations in MS
patients. This notion is also supported by our findings, showing no
Figure 1. Comparison of the high resolution SD-OCT and standard TD-OCT. Figure 1 shows high resolution SD-OCT scans (left column) and
standard TD-OCT scans (right column) of 2 MS patients. Patient 1, 34 year old female, RRMS, disease duration 15years, prior ON (left eye, 2 years after
disease onset). Patient 2, SPMS, 47 year old male, SPMS, disease duration 20 years, no prior ON. Measurements of RNFL were comparable in patient 1
but differed about 5.3 mm (OD, right eye) and 9.8 mm (OS, left eye) in patient 2 (red arrows, lower row). Baseline/reference scans of standard TD-OCT
are averaged out of 3 sequential scans (asterisks) with partly substantial differences of each single scan. Low scanning speed and prolonged
examination time of standard TD-OCT can often not compensate low image resolution despite good centering around the optic nerve as a result of
poor fixation and motion artefacts. In contrast, with high resolution SD-OCT reliable and properly centered baseline and follow up scans can be
achieved with ultrahigh speed scanning and an eye tracking mode. Moreover, with high resolution SD-OCT previous scan locations can be identified
and guide the laser beam to identical scan positions repeatedly.
doi:10.1371/journal.pone.0013877.g001
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without ON, when company standards are used.
Differences between RRMS, SPMS and age-/sex-matched
controls
Residual and q-q-plots were found to be in good agreement
with the model assumptions of the random effect models. Figures 2
and 3 give boxplots and sample sizes of RNFL measurements for
each of the four MS subgroups (group 1, RRMS without ON;
group 2, RRMS with ON; group 3, SPMS without ON and group
4, SPMS with ON) and age and sex matched controls. The main
findings may be summarized briefly as follows:
All 4 groups showed significantly reduced RNFL globally
compared to controls, and in at least in one of the peripapillary
sectors. In RRMS and SPMS patients without ON the mean RNFL
(global) was found reduced significantly (group 1, p=0.01; group 3,
p,0.0001; figure 2). The peripapillary sectors T, TI and TS of group
2-4 (p,0.05; figure 3), and in sectors N, NI and NS of group 3-4
(p,0.05; figure 3) showed reduced RNFL compared to controls. In
RRMS without ON (group 1, figure 3) the RNFL was significantly
reduced in TS (p=0.04) only. A subgroup analysis of RRMS and
SPMS with one unaffected and one affected optic nerve, showed
significant reduced global RNFL in both eyes (RRMS ON diseased
eyes, p,0.0001; RRMS, ON ‘free’ eyes, p=0.02; SPMS ON
diseased eyes, p,0.0001; SPMS, ON ‘free’ eyes, p=0.001).
Influence of disease duration or subtype of MS
Neither age nor disease duration nor MS subtype showed
statistical significant correlations. The mixed model for the mean
nerve thickness with ON (yes/no) as single fixed factor indicates an
average loss in nerve thickness associated with a prior ON episode
by 211.9 mm (95% confidence interval: 216.0 to 27.7).
Correlation of visual tests and RNFL
All visual and contrast acuity and sensitivity tests (ETDRS,
Sloan and Pelli-Robson-charts), the colour vision test (Lanthony
D-15) and the Humphrey visual field analysis had statistically
significant correlations to the RNFL measurements (all p,0.001).
Correlation of VEP and RNFL
Global RNFL reduction and RNFL reduction in the sectors T,
TI and TS were found correlated to pathologic, increased P-100
latencies (p,0.0001). An overall association of P-100 values to
RNFL was confirmed by the mixed model analysis for the average
RNFL all sectors (p,0.0001; slope 20.36; 95% CI for slope
20.40 to 20.32) as well as the robust logistic regression analysis
for the influence of the average RNFL on the likelihood for a P-
100 latency below 118 ms (p=0.0003; odd ratio, 0.94; 95% CI for
the odd ratio, 0.91 and 0.96).
Discussion
Purpose of our study was to define RNFL characteristics of
RRMS and SPMS patients at baseline with high resolution SD-
OCT technique.
Obviously, ON and technical limitations are the major factors
which may influence RNFL measurements. ON is a very
common, often initial symptom of MS, and leads to RNFL
reduction, globally or segmentally depending on the exact location
and extent of lesions within the optic nerves. Thus, most attention
must be paid to prior episodes of ON, when RNFL measurements
should serve for monitoring slow progressive axonal degeneration.
The dilemma is that careful and detailed clinical examination and
history taking, neuro-ophalmologic examination, VEP and MRI
cannot completely rule out focal lesions along the optic nerves or
visual pathways. After years patients are sometimes not able to
remember their prior ON, even if the ON was severe but achieved
full recovery. Clinical examination, VEP and MRI may be
normal. In our study pathologic VEP were found pathologic in 5
out of 13 RRMS patients (8 out of 16 eyes) with prior ON only.
Minimal changes within the optic nerves, such as (minimal)
demyelination, remyelination and gliosis, can only be verified by
biopsy, and their influence on RNFL reduction will remain
unclear even with improved OCT technique. However, whether
the lesion load (or very subtle MRI changes only detectable with
improved MR technique e.g. [6,7]) from the lateral geniculate nuclei
to the visual cortex areas consistently correlates to RNFL changes
(manuscript in preparation), and if so, whether these lesions may
affect the optic nerves and the RNFL due to retrograde
transsynaptic axonal degeneration remains under discussion (for
review see [18]). To the best of our knowledge, evidence for
retrograde transsynaptic axonal degeneration along the visual
pathways in humans is still lacking.
In most of the MS cases, the progressive axonal changes may be
elusive in short but obvious in long observations periods. To date,
no reliable tool exists to monitor diffuse axonal degeneration
during short disease intervals in MS patients who mostly follow a
primary relapsing-remitting course with clinical stable intervals
over months, years or sometimes even decades. Only rarely, the
disease follows a (fast) progressive course from the beginning.
Hence, diffuse axonal changes in the whole CNS and, if this
hypothesis is right, RNFL reduction may be expected to be very
subtle in most of the MS patients [2,5,18]. Moreover, reduced
image quality may cause differing results on RNFL measurements
within one single session as well as between follow-up visits and
make standardized comparison per se impossible [11]. Decentring,
poor fixation and eye movements must be avoided strictly during
scan acquisition as the RNFL is not homogeneous but thicker
around the optic disc [10]. The patients must be alert and able to
focus a central target to avoid decentring and to keep scan
Figure 2. Global reduction of RNFL. *p,0.05; **p,0.005;
***p,0.0001.
doi:10.1371/journal.pone.0013877.g002
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visual acuity are often impaired in MS patients [19]. For that
reasons we and others propose minimal technical requirements to
achieve high resolution baseline and reproducible follow up scans
[4,5]. To the best of our knowledge, no other study of MS patients
performed with the just recently available new high-resolution SD-
OCT device has been published.
In our cohorts of 42 RRMS and 17 SPMS patients a significant
RNFL reduction was found in all groups, with and without prior
episodes of ON.
In RRMS without ON, the RNFL reduction was observed in
the sector TS (p=0.04;) and was only evident when compared
with healthy age/sex-matched controls (group 1, figure 3). The
OCT device lacking a normative database, did not detect a
significant reduction in RNFL in the RRMS without ON (Table 2).
The inter-individual variation of RNFL is known to be high in the
normal population [1,18]. Consistent with previous studies we
found a significant loss of RNFL in RRMS patients with prior
uni,- or bilateral ON [20]. Axonal loss was evident in all
peripapillary sectors except for the NI sector as compared to the
fellow eye and disease free controls.
SPMS patients without previous ON revealed a marked RNFL
reduction in both eyes. In these patients the RNFL was found
more reduced than in age- and sex-matched controls. In SPMS
Figure 3. Segmental reduction of RNFL. *p,0.05; **p,0.005; ***p,0.0001.
doi:10.1371/journal.pone.0013877.g003
High Resolution SD-OCT in MS
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functional importance since VEP were found pathologic in 83%,
high-contrast visual acuity (EDTRS) in 50% and colour vision
testing in 33% of 12 investigated eyes.
Conclusions
RNFL reduction can be found in RRMS and to higher extent in
SPMS patients. In addition we found marked RNFL reduction in
RRMS and SPMS with ON. Underlying mechanisms, which
cause the RNFL reduction apart from ON cannot be distinguished
with OCT. RNFL reduction may be caused by secondary axonal
degeneration due to distant focal lesions in the visual pathways or
by diffuse progressive axonal degeneration due to a compartmen-
talized ongoing CNS inflammation. Thus it remains unclear if
RNFL analysis is an appropriate method for monitoring disease
progression. Prerequisite for the interpretations of OCT-investi-
gations are standardized technical requirements [4,5,18].
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